A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs. [PDF]
Tardo AM +5 more
europepmc +1 more source
Insulin analogues glargine 300 U/mL and 100 U/mL: The same active principle for two different drugs
Jacopo Angelini +3 more
openalex +2 more sources
Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study. [PDF]
Chen L +12 more
europepmc +1 more source
Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice [PDF]
core +1 more source
Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis. [PDF]
Gourdy P +7 more
europepmc +1 more source
Correction to "Effects of Insulin Glargine U300 Versus Insulin Degludec U100 on Glycemic Variability, Hypoglycemia, and Diet Evaluated by Continuous Glucose Monitoring in Type 1 Diabetes: A Retrospective Cross-Sectional Study". [PDF]
europepmc +1 more source
High-Concentration Insulin Glargine Overdose: Polyphasic Patterns of Blood Insulin Levels. [PDF]
Tsunashima H +4 more
europepmc +1 more source
Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study. [PDF]
Mohan V +10 more
europepmc +1 more source
Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study. [PDF]
Tsai PL +4 more
europepmc +1 more source
Retrospective Analysis of Once-Daily Versus Twice-Daily Insulin Glargine Dosing in Noncritically Ill Individuals. [PDF]
Hogue D, Clements J, Wright A.
europepmc +1 more source

